Ignite Creation Date:
2024-05-06 @ 2:04 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01966029
Status:
COMPLETED
Last Update Posted:
2019-09-26
First Post:
2013-09-10
Brief Title:
BMN 110 Phase 3B in Australian Patients
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Organization Data
Organization:
BioMarin Pharmaceutical
Class:
INDUSTRY
Study ID:
110-502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMarin Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None